Please see the Editorial Comment by Andetta Hunsaker discussing this article. Filling
defects identified in the pulmonary arterial tree are commonly presumed to represent an …

INTRODUCTION he annual incidence of pulmonary embolism (PE) in the United States is
reported to be 0.69 per 1,000 persons with mortality of up to 30% depending upon the size …

OBJECTIVE. The purpose of this study is to evaluate the CT and clinical characteristics of in
situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT). MATERIALS …

Little is known regarding the clinical features and course of in-situ pulmonary artery
thrombosis (PAT). The aim of the present study was to investigate the clinical characteristics …

Pulmonary thromboembolism (PTE) is the third leading cause of death in cardiovascular
diseases. PTE is believed to be caused by thrombi detached from deep veins of lower …

A rare case of extensive in situ central pulmonary artery thrombosis in primary pulmonary
hypertension (PPH) is presented. The differentiation from chronic thromboembolic …

The thrombogenic potential of Covid-19 is recognised and we read with interest the case
series of 22 patients presented by Mueller-Peltzer and colleagues [1]. Their findings of …

The most common cause of pulmonary artery filling defects on computed tomography
pulmonary angiography or magnetic resonance imaging is pulmonary thromboembolism …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct form of precapillary
pulmonary hypertension classified as group 4 by the World Symposium on Pulmonary …

Chronic pulmonary thromboembolism (CPE) is a challenging diagnosis for clinicians. It is an
often-forgotten diagnosis and can be difficult to detect and easily misdiagnosed. The …